Cormedix Inc (CRMD) Stock Price, Quote & News

Company Profile

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was in...

Industry: Biotechnology

Sector: Healthcare

Phone: 908 517 9500

Website: cormedix.com

Address:

389 Interpace Pkwy, Suite 450, Parsippany, United States

wolfofwestloop Mar. 21 at 2:02 PM

$CRMD The Saudi Arabian guy was probably really pissed off and then oil shot over $100 a barrel and he's completely forgotten about CRMD!

0 · Reply

Czar100 Mar. 21 at 12:29 PM

$CRMD Just a reminder: “There are two major pieces of legislation and one specific regulatory move that could completely change the trajectory for CorMedix. 1. The Kidney Care Access Protection Act (H.R. 6214) This is the "Holy Grail" for CorMedix. Introduced in late 2025 and gaining significant traction in March 2026 following House Ways and Means hearings, this bipartisan bill specifically addresses the "innovation gap" in dialysis. • The TDAPA Extension: The bill proposes extending the Transitional Drug Add-on Payment Adjustment (TDAPA) period beyond the current two-year limit. • Impact on CRMD: If passed, it would delay the July 2026 "cliff" where DefenCath moves from a high-margin add-on payment to a lower-margin bundled payment. This would effectively protect CorMedix's massive 90%+ margins for an additional 1–2 years, giving the company more time to launch its other products (like REZZAYO).” (More on 2nd post)

1 · Reply

Noname2022 Mar. 20 at 8:25 PM

$CRMD Will be curious to see pace of share buybacks; slow and steady or premptive bullish

1 · Reply

Noname2022 Mar. 20 at 8:24 PM

$AKBA $CRMD $FMS $DVA https://www.kidneyfund.org/article/american-kidney-fund-statement-us-house-ways-means-health-subcommittee-hearing-improving-kidney

0 · Reply

Noname2022 Mar. 20 at 5:33 PM

$AKBA $CRMD

1 · Reply

watchaddict Mar. 20 at 4:26 PM

$CRMD adding

0 · Reply

Derfzilla Mar. 20 at 3:46 PM

$CRMD

0 · Reply

ReturnOfEsquire Mar. 20 at 3:05 PM

$CRMD

0 · Reply

CRMDBear Mar. 20 at 2:39 PM

$CRMD What do we see next $5 or $7?

0 · Reply

Andy1063 Mar. 20 at 2:12 PM

$CRMD Geez, can we just get like one green pity day??

1 · Reply

CorMedix Inc. (CRMD) Q4 2025 Earnings Call Transcript

Mar 5, 2026, 12:58 PM EST - 16 days ago

CorMedix stock drops after earnings: is this dip a buy before key catalyst?

Mar 5, 2026, 7:30 AM EST - 16 days ago

CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Mar 2, 2026, 8:30 AM EST - 19 days ago

CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026

Feb 14, 2026, 2:37 AM EST - 5 weeks ago

CorMedix Inc. (CRMD) Analyst/Investor Day Transcript

Feb 12, 2026, 8:30 AM EST - 5 weeks ago

CorMedix to Participate in Upcoming Investor Conferences

Feb 2, 2026, 8:30 AM EST - 6 weeks ago

CorMedix Therapeutics Announces Share Repurchase Program

Jan 29, 2026, 8:30 AM EST - 7 weeks ago

CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026

Jan 13, 2026, 1:26 AM EST - 2 months ago

CorMedix Inc. (CRMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 9, 2026, 8:30 AM EST - 2 months ago

CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 8, 2026, 1:37 PM EST - 2 months ago

Why is CorMedix stock crashing today: is it worth buying on the dip?

Jan 8, 2026, 8:05 AM EST - 2 months ago

CorMedix Therapeutics Announces Leadership and Board Updates

Jan 8, 2026, 8:00 AM EST - 2 months ago

CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates

Dec 18, 2025, 8:00 AM EST - 3 months ago

CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath

Nov 14, 2025, 2:56 PM EST - 4 months ago

CorMedix: Raised Guidance, NOL Confidence, And Rezzayo Optionality Justify A Hold Rating

Nov 12, 2025, 4:05 PM EST - 4 months ago

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

TLPH

Nov 12, 2025, 11:49 AM EST - 4 months ago

CorMedix Q3 Profit Soars As DefenCath Dialysis Demand Exceeds Expectations

Nov 12, 2025, 11:11 AM EST - 4 months ago

CorMedix Inc. (CRMD) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 7:30 AM EST - 4 months ago

CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance

Oct 31, 2025, 8:30 AM EDT - 5 months ago

CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025

Oct 23, 2025, 11:29 PM EDT - 5 months ago

CorMedix: Strong Buy After Strong Developments And A Strategy Before Earnings

Oct 23, 2025, 8:30 AM EDT - 5 months ago

CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath

Oct 22, 2025, 4:05 PM EDT - 5 months ago

Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 20, 2025, 9:42 AM EDT - 5 months ago

CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why

CELC RANI RAPT

Oct 20, 2025, 7:30 AM EDT - 5 months ago

CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance

Sep 29, 2025, 8:30 AM EDT - 6 months ago

CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO

Sep 22, 2025, 4:46 AM EDT - 6 months ago

CorMedix: Strong Adoption Curve And Policy Environment

Sep 10, 2025, 1:18 PM EDT - 6 months ago

CorMedix Inc. (CRMD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 8:30 AM EDT - 6 months ago

CorMedix Announces Strategic Minority Investment in Talphera

TLPH

Sep 8, 2025, 8:30 AM EDT - 6 months ago

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

TLPH

Sep 2, 2025, 7:30 AM EDT - 7 months ago

CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team

Aug 26, 2025, 2:41 AM EDT - 7 months ago

CorMedix: The Undervalued Breakthrough

Aug 8, 2025, 3:16 PM EDT - 8 months ago

CorMedix, Inc. (CRMD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 10:49 AM EDT - 8 months ago

CorMedix to Buy Melinta Therapeutics for $300 Million

Aug 7, 2025, 7:10 AM EDT - 8 months ago

Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership

Aug 7, 2025, 7:00 AM EDT - 8 months ago

CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings

Aug 7, 2025, 7:00 AM EDT - 8 months ago

Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Jun 30, 2025, 2:24 PM EDT - 9 months ago

CorMedix Analyst Says Investors Could Be Further Rewarded

Jun 30, 2025, 2:14 PM EDT - 9 months ago

CorMedix Seems Significantly Undervalued

Jun 27, 2025, 9:09 AM EDT - 9 months ago

Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session

CNXC

Jun 27, 2025, 8:00 AM EDT - 9 months ago

CorMedix Inc. Announces Pricing of Public Offering of Common Stock

Jun 26, 2025, 4:01 PM EDT - 9 months ago

CorMedix Inc. Announces Proposed Public Offering of Common Stock

Jun 23, 2025, 7:30 AM EDT - 9 months ago

CorMedix inc. Announces Customer Implementation

Jun 5, 2025, 12:37 AM EDT - 10 months ago

CorMedix: DefenCath In Exponential Growth Phase With Robust Market Position

Jun 4, 2025, 12:41 PM EDT - 10 months ago

CorMedix: Exceeding Expectations

May 30, 2025, 8:30 AM EDT - 10 months ago

CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

May 15, 2025, 8:30 AM EDT - 11 months ago

CorMedix Inc. to Participate in the RBC Global Healthcare Conference

May 6, 2025, 11:59 AM EDT - 11 months ago

CorMedix, Inc. (CRMD) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:30 AM EDT - 11 months ago

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

wolfofwestloop Mar. 21 at 2:02 PM

$CRMD The Saudi Arabian guy was probably really pissed off and then oil shot over $100 a barrel and he's completely forgotten about CRMD!

0 · Reply

Czar100 Mar. 21 at 12:29 PM

1 · Reply

Noname2022 Mar. 20 at 8:25 PM

$CRMD Will be curious to see pace of share buybacks; slow and steady or premptive bullish

1 · Reply

Noname2022 Mar. 20 at 8:24 PM

$AKBA $CRMD $FMS $DVA https://www.kidneyfund.org/article/american-kidney-fund-statement-us-house-ways-means-health-subcommittee-hearing-improving-kidney

0 · Reply

Noname2022 Mar. 20 at 5:33 PM

$AKBA $CRMD

1 · Reply

watchaddict Mar. 20 at 4:26 PM

$CRMD adding

0 · Reply

Derfzilla Mar. 20 at 3:46 PM

$CRMD

0 · Reply

ReturnOfEsquire Mar. 20 at 3:05 PM

$CRMD

0 · Reply

CRMDBear Mar. 20 at 2:39 PM

$CRMD What do we see next $5 or $7?

0 · Reply

Andy1063 Mar. 20 at 2:12 PM

$CRMD Geez, can we just get like one green pity day??

1 · Reply

Stonehands Mar. 20 at 2:08 PM

$CRMD

0 · Reply

FiveDsofDodgeball Mar. 20 at 1:43 PM

$CRMD adding

0 · Reply

wolfofwestloop Mar. 20 at 3:10 AM

$CRMD If there is no form of payment nobody uses it... it could be a cure for cancer... Jersey scam artist Joe Todisco doesn't care or believe in this either. If he did he buy shares and not a shore house. He knows this isn't going to work. Noname bust out the charts...

1 · Reply

wolfofwestloop Mar. 20 at 3:06 AM

$CRMD come on guys post more evidence about how great the product is and how Joe saved the company!!! Clueless fucks!!!

0 · Reply

wolfofwestloop Mar. 20 at 2:34 AM

$CRMD The leadership team I've heard has a ridiculous sense of arrogance in a small tight Dialysis community. Liz Hurlburt has been described as a bull in a china shop... You can listen to nonames constant BS and love affair but the reality is Joe has put together a piece of shit, trash team that conducts themselves that way. We should be at a minimum $18 share price but the institutions see the trash. Georgetown Joe is running Cleveland Browns or raiders!!! We need Mike Vrabel or a legit leader not someone posting pics of the "Italian" Rb's. He's a f'n joke!!!

0 · Reply

DragonAlgo Mar. 20 at 12:30 AM

🐉 $CRMD PUT — DragonAlgo® Signal Contract: CRMD PUT Expiry: 2026-06-18 | Strike: $9.00 | Type: PUT Option Plan (premium): Entry: $2.92 Stop: $2.11 TP1: $3.80 TP2: $4.97 TP3: $7.02 System-defined risk profile. 🔗 https://dragonalgo.com

0 · Reply

Noname2022 Mar. 20 at 12:15 AM

$AKBA $CRMD $FMS $DVA

0 · Reply

Noname2022 Mar. 19 at 10:59 PM

$CRMD This case study suggests REZZAYO is effective against PJP, which has been shown in mouse models. In this patient, there was a blood level marker suggestive of PJP activity. For the respect trial, recall this represents 800M TAM if proven. “Elevated BDG levels are a recognised feature of PJP, and serial measurements can assist in monitoring the response to antifungal therapy” “The progressive decline in BDG levels observed during rezafungin administration in this patient may indicate antifungal activity; ”

0 · Reply

Noname2022 Mar. 19 at 10:03 PM

$CRMD Case study this week of RezZayo replacing bactrim; similar to respect trial… https://www.mdpi.com/2076-2607/14/3/683

0 · Reply

Andy1063 Mar. 19 at 8:52 PM

$CRMD Just a heads-up with Talphera (Niyad) on Monday... https://finance.yahoo.com/news/talphera-host-virtual-investor-analyst-200500953.html

1 · Reply

wolfofwestloop Mar. 19 at 8:34 PM

$CRMD Joe and this leadership team need to get fired ASAP!!! His performance to bring shareholder value has been absolutely horrendous and the street is telling him that with the share price being $6 and having a PE of sub 3... I can't believe what I'ver heard and witnessed from him over the last 18 months.

1 · Reply

NorDog Mar. 19 at 8:17 PM

$CRMD Is Joseph deploying troops or opening the Strait of Hormuz anytime soon?

0 · Reply

Market Cap	503.55M
Revenue (ttm)	311.71M
Net Income (ttm)	163.06M
EPS (ttm)	N/A
PE Ratio	3.62
Forward PE	9.37
Profit Margin	52.31%
Debt to Equity Ratio	0.00

Volume	2,013,000
Avg Vol	2,619,862
Day's Range	N/A - N/A
Shares Out	79.05M
Stochastic %K	12%
Beta	1.31
Analysts	Strong Sell
Price Target	$14.43